Previous close | 72.50 |
Open | 73.28 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 72.71 - 72.83 |
52-week range | 57.97 - 81.40 |
Volume | |
Avg. volume | 354,443 |
Market cap | 119.987B |
Beta (5Y monthly) | 0.44 |
PE ratio (TTM) | 0.26 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
PRINCETON, N.J., June 03, 2024--BMS' Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
PRINCETON, N.J., June 03, 2024--Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations...
PRINCETON, N.J., June 01, 2024--KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced....